Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03843294
Title Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catherine Bollard
Indications

diffuse large B-cell lymphoma

Hodgkin's lymphoma

Therapies

MultiTAA-specific T cells + Nivolumab

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.